Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Allarity Therapeutics (ALLR) Return on Capital Employed (2024 - 2025)

Allarity Therapeutics' Return on Capital Employed history spans 2 years, with the latest figure at 1.14% for Q4 2025.

  • For Q4 2025, Return on Capital Employed fell 65.0% year-over-year to 1.14%; the TTM value through Dec 2025 reached 1.14%, down 65.0%, while the annual FY2025 figure was 1.05%, N/A changed from the prior year.
  • Return on Capital Employed reached 1.14% in Q4 2025 per ALLR's latest filing, down from 0.41% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.41% in Q3 2025 to a low of 1.14% in Q4 2025.